22nd Century to Participate in the HC Wainwright Conference in New York City September 9, 2025
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference.
Rhea-AI Summary
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
Positive
- None.
Negative
- None.
Details
News Market Reaction – XXII
On Sep 8, the first trading day after this news, XXII closed 5.26% below the previous close.
Data tracked by StockTitan Argus for the Sep 8 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced that Larry Firestone, Chief Executive Officer, and Dan Otto, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the HC Wainwright Conference taking place at the Lotte New York Palace Hotel.
Investors can register and request meetings via their HC Wainwright representative or 22nd Century Investor Relations at mkreps@xxiicentury.com.
About 22nd Century Group, Inc.
22nd Century Group is pioneering the nicotine harm reduction movement in the tobacco industry enabling smokers to take control of their nicotine consumption.
We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN® cigarettes have
Our proprietary non-GMO reduced nicotine tobacco blends are made possible by comprehensive and patented technologies and tobacco plants that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with
VLN® is a registered trademark of 22nd Century Limited LLC.
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
Learn more about VLN® at tryvln.com.
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.